Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma

Meldonium (MID) is a synthetic drug designed to decrease the availability of L-carnitine—a main player in mitochondrial energy generation—thus modulating the cell pathways of energy metabolism. Its clinical effects are mostly evident in blood vessels during ischemic events, when the hyperproduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnelli, Cristina, Piva, Francesco, Cecati, Monia, Armeni, Tatiana, Mobbili, Giovanna, Galeazzi, Roberta, Melecchi, Alberto, Cristaldi, Martina, Corsaro, Roberta, Rusciano, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143983/
https://www.ncbi.nlm.nih.gov/pubmed/37111351
http://dx.doi.org/10.3390/ph16040594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143983/
https://www.ncbi.nlm.nih.gov/pubmed/37111351
http://dx.doi.org/10.3390/ph16040594

Ejemplares similares